Arkolith/Insider Trading/VIR/Form 4

More Robert J

DirectorVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Jun 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2025Other(J)14K—$0510K
Jun 9, 2025Other(J)14K—$041K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-030306) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML